In our in vitro experiments we analyzed metabolic profiles in three breast cancer cell lines with different TP53 status (wild type MCF7 and mutated TP53 in MDA-MB-231 and JIMT-1) and demonstrate that glycolytic activity is concomitant with TP53 status. Here, TP53 is linked to breast cancer.